Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07112924 · ClinicalTrials.gov registry record
CCM OPEN HF Registry
A clinical trial of Heart Failure, sponsored by Impulse Dynamics.
- Recruiting
- Registry status
- 5,500
- Enrollment target
- 1
- Study location
NCT07112924: Recruiting study of Heart Failure, sponsored by Impulse Dynamics.
NCT07112924 is a study of Heart Failure that is actively recruiting participants, run by Impulse Dynamics. The registered enrollment target is 5,500 participants, above the 2,035-participant average among 397 other Heart Failure trials with a reported enrollment target (170% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07112924, a study of Heart Failure, is actively recruiting participants, sponsored by Impulse Dynamics.
- RECRUITING
- Registry status
- 5,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Primary Outcome
Change in the HF hospitalization / urgent HF visit rate and hospital length of stay from 1 year prior to 1 year following index implantation.
Conditions Studied
Study Locations (1)
Arizona
- Cardiovascular Associates of Mesa - Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2036-08-01 |
What NCT07112924 shows while recruiting
NCT07112924 is an observational study that tracks outcomes without assigning an intervention. Its 5,500 participants enrollment target places it among the larger protocols in the corpus, above the 2,035-participant average among 397 other Heart Failure trials with a reported enrollment target (170% higher).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT07112924 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT07112924 about?
NCT07112924 is a clinical study titled "CCM OPEN HF Registry". The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
What is the current status of trial NCT07112924?
This trial is currently recruiting. The enrollment target is 5,500 participants. The study started on 2025-11-01. Estimated completion is 2036-08-01.
What conditions does trial NCT07112924 study?
This clinical trial studies the following conditions: Heart Failure.
Who is sponsoring clinical trial NCT07112924?
This trial is sponsored by Impulse Dynamics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07112924 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07112924's enrollment target sits among peer trials
5,500 16th of 397 higher than 382 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI